EYPT
EyePoint Pharmaceuticals Inc
Price:  
8.25 
USD
Volume:  
501,703.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EYPT WACC - Weighted Average Cost of Capital

The WACC of EyePoint Pharmaceuticals Inc (EYPT) is 6.1%.

The Cost of Equity of EyePoint Pharmaceuticals Inc (EYPT) is 7.40%.
The Cost of Debt of EyePoint Pharmaceuticals Inc (EYPT) is 6.60%.

Range Selected
Cost of equity 5.50% - 9.30% 7.40%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.50% - 8.70% 6.60%
WACC 4.4% - 7.9% 6.1%
WACC

EYPT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.36 0.8
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.50% 9.30%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 4.50% 8.70%
After-tax WACC 4.4% 7.9%
Selected WACC 6.1%